Inspiratory Muscle Training in Patients With Heart Failure With Preserved Ejection Fraction: A Meta-Analysis
Overview
Authors
Affiliations
Objectives To explore the role of inspiratory muscle training (IMT) in improving cardiorespiratory fitness of stable heart failure with preserved ejection fraction (HFpEF) patients. Background There is a paucity of data on the role of IMT in patients with HFpEF. HFpEF is a growing problem in the developed world, especially in the aging population. Methods We conducted a systematic literature search for English studies in PubMed, EMBASE, and Cochrane Central Register of Controlled Trials. We searched databases using terms relating to or describing breathing exercise, IMT, and HFpEF. RevMan 5.4 (The Cochrane Collaboration, 2020) was used for data analysis, and two independent investigators performed literature retrieval and data extraction. Results We identified three randomized controlled trials (RCTs) and one prospective study on the role of IMT in HFpEF. We calculated the pooled mean difference of peak oxygen consumption (Peak VO) and six-min walk distance (6MWD) between the IMT and standard care (SC) groups. Our meta-analysis showed that compared with SC, IMT could significantly improve peak VO with a mean difference (MD) of 2.82 ml/kg/min, 95% CI [1.90, 3.74] P < 0.00001 and improve 6MWD with MD of 83.97 meters, 95% CI [59.18, 108.76] P< 0.00001 to improve cardiorespiratory fitness at 12 weeks of IMT and improve peak VO with MD of 2.18 ml/kg/min, 95% CI [0.38, 3.99] P < 0.00001 at 24 weeks of therapy. Conclusion IMT should be further studied as a possible treatment option to improve cardiorespiratory fitness for patients with stable HFpEF.
Mechanisms of exercise intolerance in hear-t failure with preserved ejection fraction (HFpEF).
Pecchia B, Samuel R, Shah V, Newman E, Gibson G Heart Fail Rev. 2025; .
PMID: 40080287 DOI: 10.1007/s10741-025-10504-3.
Exercise Training in Patients with Heart Failure: From Pathophysiology to Exercise Prescription.
Cuomo G, Di Lorenzo A, Tramontano A, Iannone F, DAngelo A, Pezzella R Rev Cardiovasc Med. 2024; 23(4):144.
PMID: 39076241 PMC: 11273657. DOI: 10.31083/j.rcm2304144.
Locomotor and respiratory muscle abnormalities in HFrEF and HFpEF.
Mangner N, Winzer E, Linke A, Adams V Front Cardiovasc Med. 2023; 10:1149065.
PMID: 37965088 PMC: 10641491. DOI: 10.3389/fcvm.2023.1149065.
Baral N, Gautam S, Yadav S, Poudel S, Adhikari G, Rauniyar R Cureus. 2021; 13(2):e13604.
PMID: 33816003 PMC: 8009057. DOI: 10.7759/cureus.13604.